NCT06883266 Transcranial Direct Current Stimulation for Motor Function and Fatigue in PD
| NCT ID | NCT06883266 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sanford Health |
| Condition | Parkinsons Disease (PD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 64 participants |
| Start Date | 2024-11-11 |
| Primary Completion | 2026-11-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 64 participants in total. It began in 2024-11-11 with a primary completion date of 2026-11-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators hypothesize that multi-session anodal tDCS (atDCS) of the left primary motor cortex (M1) will induce long-lasting effects in improving motor function and reducing motor fatigue and fatigability in PD patients.
Eligibility Criteria
Inclusion Criteria: * Clinical diagnosis of PD with at least two of the four diagnostic criteria for PD (tremor, rigidity, bradykinesia, and postural instability) * Must be able to consent Exclusion Criteria: * Patients with dementia (MOCA \< 21) * PD treatment using deep brain stimulation (DBS) * Diagnosis of psychosis * Diagnosis of multiple sclerosis * Diagnosis of stroke * Diagnosis of chronic obstructive pulmonary disease (COPD) * Diagnosis of congestive heart failure (CHF)
Contact & Investigator
Jau-Shin Lou, MD
PRINCIPAL INVESTIGATOR
Sanford Health
Frequently Asked Questions
Who can join the NCT06883266 clinical trial?
This trial is open to participants of all sexes, studying Parkinsons Disease (PD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06883266 currently recruiting?
Yes, NCT06883266 is actively recruiting participants. Contact the research team at jessica.keller@sanfordhealth.org for enrollment information.
Where is the NCT06883266 trial being conducted?
This trial is being conducted at Fargo, United States.
Who is sponsoring the NCT06883266 clinical trial?
NCT06883266 is sponsored by Sanford Health. The principal investigator is Jau-Shin Lou, MD at Sanford Health. The trial plans to enroll 64 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.